================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13E-3
RULE 13E-3 TRANSACTION STATEMENT
(Pursuant to Section 13(e) of the Securities Exchange Act of 1934)
Amendment No. 3
---------------
CONCENTRA MANAGED CARE, INC.
(Name of the Issuer)
Welsh, Carson, Anderson & Stowe, VIII, L.P.
Yankee Acquisition Corp.
John K. Carlyle
W. Tom Fogarty, M.D.
James M. Greenwood
Thomas E. Kiraly
Kenneth Loffredo
Richard A. Parr II
Daniel J. Thomas
Concentra Managed Care, Inc.
(Name of Person(s) Filing Statement)
---------------
COMMON STOCK, PAR VALUE $.01 PER SHARE
(Title of Class of Securities)
---------------
20589T103
(CUSIP Number of Class of Securities)
- --------------------------------------------------------------------------------
Paul B. Queally
Yankee Acquisition Corp
c/o Welsh, Carson, Anderson & Stowe VIII, L.P.
320 Park Avenue
New York, New York 10022
(212) 893-9500
- --------------------------------------------------------------------------------
Daniel J. Thomas
Concentra Managed Care, Inc.
312 Union Wharf
Boston, Massachusetts 02109
(617) 367-2163
- --------------------------------------------------------------------------------
WITH COPIES TO:
- --------------------------------------------------------------------------------
Robert A. Schwed, Esq.
Othon A. Prounis, Esq.
Reboul, MacMurray, Hewitt,
Maynard & Kristol
45 Rockefeller Plaza
New York, New York 10111
(212) 841-5700
- --------------------------------------------------------------------------------
Richard A. Parr II
Concentra Managed Care, Inc.
5080 Spectrum Drive
Suite 400, West Tower
Addison, Texas 75001
(800) 232-3550
- --------------------------------------------------------------------------------
Jeffrey A. Chapman, Esq.
Vinson & Elkins L.L.P.
3700 Trammell Crow Center
2001 Ross Avenue
Dallas, Texas 75201-2975
(214) 220-7795
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications on Behalf of Person(s) Filing Statement)
This statement is filed in connection with (check the appropriate box):
a. / X / The filing of solicitation materials or an
information statement subject to Regulation 14A,
Regulation 14C, or Rule 13e-3(c) under the Securities
Exchange Act of 1934.
b. / / The filing of a registration statement under the
Securities Act of 1933.
c. / / A tender offer.
d. / / None of the above.
Check the following box if the soliciting materials or information
statement referred to in checking box (a) are preliminary copies: /X/
CALCULATION OF FILING FEE
- --------------------------------------------------------------------------------
TRANSACTION VALUATION (1) AMOUNT OF FILING FEE
- --------------------------------------------------------------------------------
$ 792,505,929.90 $ 158,501.19
- --------------------------------------------------------------------------------
/X/ Check box if any part of the fee is offset as provided by Rule 0-11(a)
(2) and identify the filing with which the offsetting fee was
previously paid. Identify the previous filing by registration statement
number, or the form or schedule and the date of its filing.
Amount previously paid: $158,501.19
Form or registration no.: Schedule 14A - Preliminary
Proxy Statement
Filing Party: Concentra Managed Care, Inc.
Dated filed: March 31, 1999
(1) For purposes of calculating the fee only. Assumes purchase of
47,294,074 shares of common stock, par value $.01 per share, of Concentra
Managed Care, Inc. at $16.50 per share and the purchase of underlying options to
purchase Common Stock for an aggregate of $12,153,708.90
================================================================================
<PAGE>
EXPLANATORY NOTE
The purpose of Amendment No. 3 to Concentra's Rule 13e-3 Transaction
Statement is to file revised (d)(3), which is Amendment No. 5 to the proxy
statement for the Special Meeting of Shareholders to approve the rule 13e-3
transaction.
<PAGE>
ITEM 17. MATERIAL TO BE FILED AS EXHIBITS.
- --------------------------------------------------------------------------------
EXHIBIT NO. DESCRIPTION
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
(a)(1)* Commitment Letter dated February 26, 1999 from Chase
Securities Inc., The Chase Manhattan Bank, DLJ Capital
Funding, Inc., Credit Suisse First Boston and Fleet
National Bank.
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
(a)(2)* Letter dated February 24, 1999 from Chase Capital
Partners.
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
(a)(3)* Letter dated March 1, 1999 from WCAS Capital Partners III,
L.P.
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
(b)(1) Opinion of BT Alex. Brown Incorporated dated March 2, 1999
(included as Appendix B to the Definitive Proxy
Statement, which is filed herewith as Exhibit (d)(3)).
- --------------------------------------------------------------------------------
(b)(2)* Financial Analysis Presentation materials prepared by BT
Alex. Brown Incorporated in connection with its opinion
dated March 2, 1999 to Concentra's board of directors and
special committee.
------------------------------------------------------------------------------
(c)(1) Agreement and Plan of Merger dated as of March 24, 1999 by
and between Yankee
- --------------------------------------------------------------------------------
<PAGE>
- -------------------------------------------------------------------------------
EXHIBIT NO. DESCRIPTION
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
Acquisition Corp. and Concentra Managed Care, Inc.
(included as Appendix A to the Definitive Proxy
Statement, which is filed herewith as Exhibit (d)(3)).
- -------------------------------------------------------------------------------
(c)(2)* Contribution Letter dated March 24, 1999 by Welsh, Carson,
Anderson & Stowe VIII, L.P.
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
(c)(3)* Stock Subscription Agreement dated as of March 24, 1999 by
Ferrer Freeman Thompson & Co. on behalf of Health Care
Capital Partners L.P. and on behalf of Health Care
Executive Partners and Yankee Acquisition Corp.
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
(d)(1) Letter to Stockholders (included in the Definitive Proxy
Statement, which is filed herewith as Exhibit (d)(3)).
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
(d)(2) Notice of Special Meeting of Stockholders (included in the
Definitive Proxy Statement, which is filed herewith as
Exhibit (d)(3)).
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
(d)(3) Amendment No. 5 to Definitive Proxy Statement (incorporated
by reference to Amendment No. 5 the Schedule 14A filed
by Concentra on July 16, 1999).
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
(d)(4)* Form of Proxy.
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
(d)(5) Press Release issued by Concentra Managed Care, Inc. dated
as of April 28, 1999 (incorporated by reference to the
Current Report on Form 8-K filed by Concentra on April 28,
1999).
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
(d)(6) Press Release issued by Concentra Managed Care, Inc. dated
as of March 3, 1999 (incorporated by reference to the
Current Report on Form 8-K filed by Concentra on March 3,
1999).
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
(d)(7) Press Release issued by Concentra Managed Care, Inc. dated
as of March 25, 1999 (incorporated by reference to the
Current Report on Form 8-K filed by Concentra on March 29,
1999).
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
(e) Text of Section 262 of the Delaware General Corporation
Law (included as Appendix C to the Preliminary Proxy
Statement, which is filed herewith as Exhibit (d)(3)).
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
(f) Not applicable.
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
99.1* Powers of Attorney.
- -------------------------------------------------------------------------------
- --------------
* Previously filed
<PAGE>
SIGNATURES
After due inquiry and to the best of our knowledge and belief, each of
the undersigned certifies that the information set forth in this Statement is
true, complete and correct.
CONCENTRA MANAGED CARE, INC.
By: /s/ Daniel J. Thomas*
-----------------------------------
Daniel J. Thomas
Dated: July 16, 1999 President
YANKEE ACQUISITION CORP.
By: /s/ Paul B. Queally
-----------------------------------
Paul B. Queally
Dated: July 16, 1999 President
WELSH, CARSON, ANDERSON & STOWE, VIII, L.P.
By: WCAS VIII Associates, LLC, General Partner
By: /s/ Paul B. Queally
-----------------------------------
Paul B. Queally
Dated: July 16, 1999 Managing Member
JOHN K. CARLYLE
/s/ John K. Carlyle*
Dated: July 16, 1999 --------------------------------------------------
W. TOM FOGARTY, M.D.
/s/ W. Tom Fogarty, M.D.*
Dated: July 16, 1999 --------------------------------------------------
JAMES M. GREENWOOD
/s/ James M. Greenwood*
Dated: July 16, 1999 --------------------------------------------------
THOMAS E. KIRALY
/s/ Thomas E. Kiraly*
Dated: July 16, 1999 --------------------------------------------------
KENNETH LOFFREDO
/s/ Kenneth Loffredo*
Dated: July 16, 1999 --------------------------------------------------
RICHARD A. PARR II
/s/ Richard A. Parr II
Dated: July 16, 1999 --------------------------------------------------
DANIEL J. THOMAS
/s/ Daniel J. Thomas*
Dated: July 16, 1999 --------------------------------------------------
*The undersigned, by signing his name hereto, does sign and execute this
Schedule 13E-3 as of this 1st day of July, 1999 pursuant to the Powers of
Attorney executed on behalf of the above-named officers and directors as
previously filed with the Securities and Exchange Commission
By: /s/ Richard A. Parr II
--------------------------------------------------
Richard A. Parr II
Attorney-in-Fact
